Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice.
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
14 Dec 2023
14 Dec 2023
Historique:
pubmed:
17
11
2023
medline:
17
11
2023
entrez:
16
11
2023
Statut:
ppublish
Résumé
Recent studies have shown that the epigenetic protein histone deacetylase 11 (HDAC11) is highly expressed in the brain and critically modulates neuroimmune functions, making it a potential therapeutic target for neurological disorders. Herein, we report the development of PB94, which is a novel HDAC11 inhibitor. PB94 exhibited potency and selectivity against HDAC11 with IC
Identifiants
pubmed: 37972387
doi: 10.1021/acs.jmedchem.3c01491
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM